Color, a San Francisco, CA-based health technology company committed to advancing public health, raised $167m in Series D financing.
The round, which brings total funding raised to date to $278m, with a valuation of $1.5 billion, was led by General Catalyst and funds and accounts advised by T. Rowe Price Associates, Inc., with participation from Viking Global Investors and others.
The company will use the funding to expand its work building public health technology and infrastructure for governments, employers, and other institutions that serve large populations.
Led by CEO Othman Laraki, Color is a distributed healthcare and clinical testing company which offers population-scale healthcare programs. The company works with health systems, employers, and national health initiatives around the world, including the million-person All of Us Research Program by the National Institutes of Health.
Through partnerships with public and private institutions such as the City of San Francisco, the Teamsters Union, the National Institutes of Health, Salesforce, the State of California, and United Airlines, Color’s infrastructure and software enables large populations to receive essential healthcare services directly where they live or work. These include testing and telehealth services for preventive health and infectious disease management. In addition to national COVID-19 testing programs and preventive healthcare services like genetic testing and counseling, the company is rolling out vaccine delivery systems to state and local governments, employers, and higher education institutions.
With this financing, Color is announcing key additions to the leadership team to scale company operations, including:
- Claire Vo as Chief Product Officer,
- Emily Reuter as Vice President of Strategy & Operations, and
- Ashley Chandler as Vice President of Marketing.